Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioquell Regulatory News (BQE)

  • There is currently no data for BQE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - BIOQUELL PLC

8 Jan 2019 09:50

RNS Number : 5029M
ODDO BHF Asset Management SAS
08 January 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Oddo Meriten Asset Management SAS

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BIOQUELL PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

07/01/2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

72 673

0.33%

(2) Cash-settled derivatives:

 

399 000

1.78%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

471 673

2.11%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary

Purchase

72 673

580 GBp

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

CFD

Increasing a long position

229 000

580 GBp

 

 (c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

08/01/2019

Contact name:

Lou PINHEIRO

 

+33 1 44 51 81 38

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETGCGDBSSGBGCI
Date   Source Headline
30th Nov 201810:59 amRNSForm 8.3 - Bioquell
30th Nov 20187:05 amRNSOffer by Ecolab U.S. 2 Inc.
12th Nov 20184:31 pmRNSHolding(s) in Company - Replacement
9th Nov 201810:22 amRNSBlock listing Interim Review
7th Nov 20183:31 pmRNSHolding(s) in Company - Replacement
7th Nov 20189:12 amRNSHolding(s) in Company
3rd Sep 20187:47 amRNSTotal Voting Rights
1st Aug 20183:38 pmRNSTotal Voting Rights
24th Jul 20187:00 amRNSHalf-year Report
2nd Jul 20183:34 pmRNSTotal Voting Rights
11th Jun 20189:26 amRNSStatement re Block Listing Application
1st Jun 201812:02 pmRNSTotal Voting Rights
25th May 20188:05 amRNSDisposal
8th May 201810:18 amRNSBlock listing Interim Review
2nd May 201811:11 amRNSStatement re Purchase of Own Shares
1st May 20188:55 amRNSStatement re Purchase of Own Shares
30th Apr 20189:36 amRNSStatement re Purchase of Own Shares
27th Apr 20188:19 amRNSStatement re Purchase of Own Shares
26th Apr 201810:58 amRNSStatement re Purchase of Own Shares
25th Apr 20182:26 pmRNSStatement re Purchase of Own Shares
24th Apr 201810:04 amRNSStatement re Purchase of Own Shares
23rd Apr 20183:49 pmRNSResult of AGM
23rd Apr 20187:00 amRNSAGM Statement
21st Mar 20187:58 amRNSAnnual Financial Report
12th Mar 20189:13 amRNSHolding(s) in Company
7th Mar 20187:00 amRNSFinal Results
9th Jan 20187:00 amRNSTrading Statement
8th Jan 20183:39 pmRNSFurther re Disposal
2nd Jan 201811:54 amRNSTotal Voting Rights
9th Nov 201712:49 pmRNSBlock listing Interim Review
2nd Oct 20177:51 amRNSTotal Voting Rights
22nd Aug 20172:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20172:08 pmRNSDisposal
26th Jul 20177:00 amRNSHalf-year Report
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 201712:48 pmRNSMiscellaneous replacement - Purchase of Own Shares
30th Jun 201712:45 pmRNSStatement Re Purchase of Own Shares
29th Jun 20178:59 amRNSStatement re Purchase of Own Shares
27th Jun 20179:19 amRNSStatement re Purchase of Own Shares
16th Jun 20178:35 amRNSStatement re Purchase of own shares
12th Jun 201710:39 amRNSStatement re Purchase of Own Shares
5th Jun 20178:28 amRNSStatement re Purchase of own shares
1st Jun 20171:07 pmRNSDirector/PDMR Shareholding
17th May 20174:31 pmRNSDirector/PDMR Shareholding
9th May 201710:24 amRNSBlock listing Interim Review
9th May 20178:51 amRNSStatement re Purchase of Own Shares
4th May 20173:00 pmRNSStatement re Block Listing Application
3rd May 201711:57 amRNSDirector/PDMR Shareholding
3rd May 20177:00 amRNSStatement re Share Buyback Programme
2nd May 201712:38 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.